These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32606113)

  • 21. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.
    José FF; Kerbauy LN; Perini GF; Blumenschein DI; Pasqualin DDC; Malheiros DMAC; Campos Neto GC; de Souza Santos FP; Piovesan R; Hamerschlak N
    Medicine (Baltimore); 2017 Mar; 96(13):e6271. PubMed ID: 28353560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed diagnosis of TAFRO syndrome: A case report.
    Qiao Y; Zhang X; Xu R; Jia X; Wang Q
    Medicine (Baltimore); 2024 Aug; 103(31):e39148. PubMed ID: 39093747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
    Noda Y; Saka Y; Kato A; Mimura T; Naruse T
    Clin Nephrol Case Stud; 2018; 6():16-20. PubMed ID: 30009125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.
    Iwasaki T; Mizusaki K; Masumoto M; Minagawa Y; Azuma K; Furukawa T; Yoshida M; Kuragano T
    BMC Nephrol; 2022 Jul; 23(1):262. PubMed ID: 35870879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
    Wakiya R; Kameda T; Takeuchi Y; Ozaki H; Nakashima S; Shimada H; Kadowaki N; Dobashi H
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):145-151. PubMed ID: 33269653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
    Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome.
    Mizuno H; Sawa N; Watanabe S; Ikuma D; Sekine A; Kawada M; Yamanouchi M; Hasegawa E; Suwabe T; Hoshino J; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Nagata M; Yamaguchi Y; Ubara Y
    Kidney Int Rep; 2020 Aug; 5(8):1172-1179. PubMed ID: 32775816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAFRO syndrome: A disease that known is half cured.
    Chen T; Feng C; Zhang X; Zhou J
    Hematol Oncol; 2023 Aug; 41(3):310-322. PubMed ID: 36148768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
    Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
    Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.
    Sato H; Kanno A; Sato M; Endo A; Ito H; Ohara T; Shirota Y; Sumitomo K; Mori T; Furukawa K
    Front Immunol; 2023; 14():1266187. PubMed ID: 37901232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To and TAFRO - a cryptic cause of acute renal failure: a case report.
    Shah N; Davidson T; Cheung C; Keung K
    BMC Nephrol; 2022 Jan; 23(1):19. PubMed ID: 34991522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAFRO Syndrome: A Disease Requiring Immediate Medical Attention.
    Masaki Y; Ueda Y; Yanagisawa H; Arita K; Sakai T; Yamada K; Mizuta S; Fukushima T; Takai K; Aoki S; Kawabata H
    Intern Med; 2023 Jan; 62(1):27-32. PubMed ID: 35598998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
    Jouvray M; Terriou L; Meignin V; Bouchindhomme B; Jourdain M; Lambert M; Lefevre G; Hachulla E; Hatron PY; Galicier L; Launay D
    Rev Med Interne; 2016 Jan; 37(1):53-7. PubMed ID: 26411598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.
    Kubokawa I; Yachie A; Hayakawa A; Hirase S; Yamamoto N; Mori T; Yanai T; Takeshima Y; Kyo E; Kageyama G; Nagai H; Uehara K; Kojima M; Iijima K
    BMC Pediatr; 2014 Jun; 14():139. PubMed ID: 24890946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the clinical characteristics of TAFRO syndrome and idiopathic multicentric Castleman disease in general internal medicine: a 6-year retrospective study.
    Nishimura Y; Hanayama Y; Fujii N; Kondo E; Otsuka F
    Intern Med J; 2020 Feb; 50(2):184-191. PubMed ID: 31211492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Campylobacter jejuni infection in patients with Castleman-Kojima disease (idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome).
    Kageyama C; Igawa T; Gion Y; Iwaki N; Tabata T; Tanaka T; Kondo E; Sakai H; Tsuneyama K; Nomoto K; Noguchi H; Yoshino T; Yokota K; Sato Y
    Pathol Int; 2019 Oct; 69(10):572-579. PubMed ID: 31631463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.
    Ohta T; Oda N; Saito K; Tamiya S; Ueno T
    Cureus; 2020 Dec; 12(12):e12175. PubMed ID: 33489586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membranoproliferative glomerulonephritis-like findings for TAFRO syndrome, associated with an anterior mediastinal tumor: A case report.
    Furuto Y; Hashimoto H; Horiuti H; Shibuya Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11057. PubMed ID: 29901607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.